SCHEMBL5331774

SCHEMBL5331774

COc1cccc(-c2csc3nc(C(C)(C)C)cn23)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.44
TP53 P04637 2/20 0.44
GAA P10253 1/20 0.44
ALDH1A1 P00352 4/20 0.43
RIPK2 O43353 1/20 0.43
SMN1; SMN2 Q16637 4/20 0.41
POLB P06746 2/20 0.41
RXFP1 Q9HBX9 1/20 0.41
NPC1 O15118 2/20 0.40
HTT P42858 2/20 0.40
RAB9A P51151 2/20 0.40
HPGD P15428 1/20 0.40
HSD17B10 Q99714 1/20 0.40
LMNA P02545 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
CYP19A1 P11511 1/20 0.40
KDM4E B2RXH2 1/20 0.40
BRD9 Q9H8M2 1/20 0.39
EGLN2 Q96KS0 1/20 0.39
KMT2A Q03164 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5329361 0.99 MAPT (0.44) MAPTTP53GAAALDH1A1RIPK2
SCHEMBL5324933 0.82 CA12 (0.44) MAPTTP53GAAALDH1A1SMN1; SMN2
Hydrochloric Acid SCHEMBL5329353 0.81 CA12 (0.43) MAPTTP53GAAALDH1A1SMN1; SMN2
SCHEMBL5325647 0.81 PDE4D (0.42) MAPTTP53ALDH1A1RIPK2NPC1
SCHEMBL5333614 0.81 WDR5 (0.38) MAPTTP53GAAALDH1A1RIPK2
Hydrochloric Acid SCHEMBL5329702 0.81 PDE4D (0.42) MAPTTP53ALDH1A1RIPK2NPC1
SCHEMBL5331798 0.81 MAPT (0.42) MAPTTP53SMN1; SMN2POLBNPC1
Hydrochloric Acid SCHEMBL5331422 0.80 WDR5 (0.37) MAPTTP53GAAALDH1A1RIPK2
Hydrochloric Acid SCHEMBL5332272 0.80 MAPT (0.41) MAPTTP53SMN1; SMN2POLBNPC1
SCHEMBL5328679 0.79 ALDH1A1 (0.43) MAPTTP53GAAALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070299113-A1 Metabotropic glutamate receptor modulators MERZ PHARMA GMBH & CO. KGAA (DE) 2007-12-27 US claimed
WO-2007148113-A1 METABOTROPIC GLUTAMATE RECEPTOR MODULATORS MERZ PHARMA GMBH & CO. KGAA (DE) 2007-12-27 WO claimed
US-20070299113-A1 Metabotropic glutamate receptor modulators MERZ PHARMA GMBH & CO. KGAA (DE) 2007-12-27 US disclosed
US-20070299113-A1 Metabotropic glutamate receptor modulators MERZ PHARMA GMBH & CO. KGAA (DE) 2007-12-27 US disclosed
US-20070299113-A1 Metabotropic glutamate receptor modulators MERZ PHARMA GMBH & CO. KGAA (DE) 2007-12-27 US disclosed
WO-2007148113-A1 METABOTROPIC GLUTAMATE RECEPTOR MODULATORS MERZ PHARMA GMBH & CO. KGAA (DE) 2007-12-27 WO disclosed
WO-2007148113-A1 METABOTROPIC GLUTAMATE RECEPTOR MODULATORS MERZ PHARMA GMBH & CO. KGAA (DE) 2007-12-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299113-A1 Metabotropic glutamate receptor modulators GRM1, GRM2, GRM3 MAPT 794/4885TP53 4870/4885GAA 3509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.